Stock HRGN HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Harvard Apparatus Regenerative Technology Inc.

Equities

HRGN

US09074M2026

Market Closed - OTC Markets
Other stock markets
 11:09:40 25/04/2024 pm IST 		5-day change 1st Jan Change
2.39 USD +3.02% Intraday chart for Harvard Apparatus Regenerative Technology Inc. +3.02% -52.10%
15/04 Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding CI
28/03 Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Biostage, Inc. Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease
Biostage, Inc. Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease
Biostage Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Biostage, Inc. Appoints Ron Packard to Board of Directors
Biostage, Inc. Auditor Raises 'Going Concern' Doubt
Biostage, Inc Announces Board Changes
Biostage, Inc Announces Executive Changes
Biostage, Inc. Amends CEO Employment Agreement
Biostage, Inc. Announces New Publication Demonstrates Rapid Esophageal Regeneration Using the Biostage Esophageal Implant
Insider Sell: Biostage
Biostage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Biostage, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Biostage, Inc. Announces Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Journal of Biomechanics
Insider Buy: Biostage
Insider Buy: Biostage
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRGN Stock
  4. News Harvard Apparatus Regenerative Technology Inc.
  5. Other languages